Brief: China NT Pharma Group Co Posts FY Loss Attributable Rmb957.7 Mln
29/03/2019 16:18
March 29 (Reuters) - China NT Pharma Group Co Ltd 1011.HK :
* FY LOSS ATTRIBUTABLE RMB957.7 MILLION VERSUS PROFIT OF
RMB165.2
MILLION
* FY REVENUE FROM CONTINUING OPERATIONS RMB571.5 MILLION
VERSUS
RMB604.8 MILLION
Source text for Eikon: ID:nHKS4Pdqjn
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma
See all newsBrief: China NT Pharma Receives Cietac Beijing Arbitration Award On July 20
Brief: China NT Pharma Establishes Formal Whistleblowing Policy
Brief: China NT Pharma Group Says Zhang Bozhi Resigns As CEO
Brief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY